Insights

Partnership Opportunities Editas Medicine has recently extended collaborations with Bristol Myers Squibb, presenting potential partnership opportunities for joint research, development, and commercialization of gene editing therapies for cancer and autoimmune diseases.

Innovative Genome Editing Tools Due to ongoing development of genome editing tools by Editas Medicine, there is a chance for sales of these tools to Bristol Myers Squibb, as per the agreement terms, providing revenue generation possibilities.

Therapeutic Pipeline Expansion With Editas working on therapies like reni-cel for Sickle Cell Disease and beta-thalassemia, there is a potential for future sales of these novel treatments, offering opportunities for market penetration and revenue growth.

Patent Victory Benefits As Editas Medicine has successfully resolved patent disputes, there may be increased investor confidence and potential for attracting more funding, which can lead to further business growth and expansion.

Revenue Growth Prospects With revenue between $50-100 million and a funding of $125 million, Editas Medicine shows financial stability, creating a favorable environment for potential investors and sales prospects for products in development.

Editas Medicine Tech Stack

Editas Medicine uses 8 technology products and services including SiteCatalyst, Power BI, MySQL, and more. Explore Editas Medicine's tech stack below.

  • SiteCatalyst
    Analytics
  • Power BI
    Business Intelligence
  • MySQL
    Database
  • ComplianceWire
    Education Management
  • jQuery
    Javascript Libraries
  • Hammer.js
    Javascript Libraries
  • Cisco Meraki
    Network Hardware
  • Linkedin
    Widgets

Media & News

Editas Medicine's Email Address Formats

Editas Medicine uses at least 2 format(s):
Editas Medicine Email FormatsExamplePercentage
first.last@editasmed.comJohn.Doe@editasmed.com
99%
last@editasmed.comDoe@editasmed.com
0%
first.l@editasmed.comJohn.D@editasmed.com
1%
last.first@editasmed.comDoe.John@editasmed.com
0%
last@editasmedicine.comDoe@editasmedicine.com
90%
flast@editasmedicine.comJDoe@editasmedicine.com
7%
first_last@editasmedicine.comJohn_Doe@editasmedicine.com
2%
first@editasmedicine.comJohn@editasmedicine.com
1%

Frequently Asked Questions

Where is Editas Medicine's headquarters located?

Minus sign iconPlus sign icon
Editas Medicine's main headquarters is located at 11 Hurley St Cambridge, Massachusetts 02141 US. The company has employees across 4 continents, including North AmericaAsiaAfrica.

What is Editas Medicine's phone number?

Minus sign iconPlus sign icon
You can contact Editas Medicine's main corporate office by phone at +1-617-401-9000. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Editas Medicine's stock symbol?

Minus sign iconPlus sign icon
Editas Medicine is a publicly traded company; the company's stock symbol is EDIT.

What is Editas Medicine's official website and social media links?

Minus sign iconPlus sign icon
Editas Medicine's official website is editasmedicine.com and has social profiles on LinkedIn.

How much revenue does Editas Medicine generate?

Minus sign iconPlus sign icon
As of May 2024, Editas Medicine's annual revenue reached $75M.

What is Editas Medicine's SIC code NAICS code?

Minus sign iconPlus sign icon
Editas Medicine's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Editas Medicine have currently?

Minus sign iconPlus sign icon
As of May 2024, Editas Medicine has approximately 318 employees across 4 continents, including North AmericaAsiaAfrica. Key team members include Chief Executive Officer: K. B.Chief Financial Officer: E. J. L.Chief Commercial & Strategy Officer: C. D.. Explore Editas Medicine's employee directory with LeadIQ.

What industry does Editas Medicine belong to?

Minus sign iconPlus sign icon
Editas Medicine operates in the Biotechnology Research industry.

What technology does Editas Medicine use?

Minus sign iconPlus sign icon
Editas Medicine's tech stack includes SiteCatalystPower BIMySQLComplianceWirejQueryHammer.jsCisco MerakiLinkedin.

What is Editas Medicine's email format?

Minus sign iconPlus sign icon
Editas Medicine's email format typically follows the pattern of . Find more Editas Medicine email formats with LeadIQ.

How much funding has Editas Medicine raised to date?

Minus sign iconPlus sign icon
As of May 2024, Editas Medicine has raised $125M in funding. The last funding round occurred on Jun 14, 2023.

When was Editas Medicine founded?

Minus sign iconPlus sign icon
Editas Medicine was founded in 2013.
Editas Medicine

Editas Medicine

Biotechnology ResearchMassachusetts, United States201-500 Employees

What if you could repair broken genes? That is the question we ask ourselves every day at Editas Medicine. We’re a clinical stage genome editing company focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases.

We are a vibrant company full of hope, possibilities, and a belief that, working together as One Editas, we can truly revolutionize the development of medicines. We are on an important journey to unlock the full potential of genome editing technology. A journey fueled by our distinct culture, expert team of Editas Medicine ‘Editors’, and the patients we aspire to help around the world. Connect with us to hear about the tremendous progress and scientific advancements we’ve already made and the next breakthrough on the horizon. If you are ingenious, passionate and resilient, come join the revolution. Repairing broken genes is only the beginning. 

Section iconCompany Overview

Headquarters
11 Hurley St Cambridge, Massachusetts 02141 US
Phone number
+1-617-401-9000
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
EDIT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconFunding & Financials

  • $125M

    Editas Medicine has raised a total of $125M of funding over 7 rounds. Their latest funding round was raised on Jun 14, 2023.

  • $50M$100M

    Editas Medicine's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $125M

    Editas Medicine has raised a total of $125M of funding over 7 rounds. Their latest funding round was raised on Jun 14, 2023.

  • $50M$100M

    Editas Medicine's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.